DNTH — Dianthus Therapeutics
Median target
$132
calls from the last 12 months
Implied return
+30.5%
median target vs. price
Coverage
17 analysts · 18 calls
updated in the last 12 months
Consensus
16/1/0+16 net
Buy / Hold / Sell
Which analysts are behind DNTH's consensus?
See every current rating, price target and the analysts' track records for Dianthus Therapeutics — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 17 analysts with calls on DNTH updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
DNTH elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-09-17 | Insiders | Carr EdwardCHIEF ACCOUNTING OFFICER | Insider sale | 7.9K sh @ $100.43 · planned trade | $796K |
| 2026-09-17 | Insiders | Carr EdwardCHIEF ACCOUNTING OFFICER | Insider sale | 6.8K sh @ $101.37 · planned trade | $686K |
| 2026-09-17 | Insiders | Carr EdwardCHIEF ACCOUNTING OFFICER | Insider sale | 3.5K sh @ $102.39 · planned trade | $358K |
| 2026-09-17 | Insiders | Carr EdwardCHIEF ACCOUNTING OFFICER | Insider sale | 1.1K sh @ $103.20 · planned trade | $114K |
| 2026-09-17 | Insiders | Carr EdwardCHIEF ACCOUNTING OFFICER | Insider sale | 700 sh @ $104.39 · planned trade | $73K |
| 2026-09-01 | Insiders | Randhawa SimratEVP, Head of R&D | Insider sale | 13.3K sh @ $106.74 · planned trade | $1.4M |
| 2026-09-01 | Insiders | Randhawa SimratEVP, Head of R&D | Insider sale | 7.2K sh @ $106.25 · planned trade | $767K |
| 2026-09-01 | Insiders | Randhawa SimratEVP, Head of R&D | Insider sale | 2.6K sh @ $105.19 · planned trade | $273K |
| 2026-08-19 | Insiders | Read SimonDirector | Insider sale | 2.8K sh @ $117.55 · planned trade | $327K |
| 2026-08-10 | Insiders | Veness Adam MSVP, General Counsel and | Insider sale | 16.2K sh @ $110.38 · planned trade | $1.8M |
More: insider activity · executive branch · trending